Development of SMEs and heterogeneity of trajectories: the case of biotechnology in France

By Vincent Mangematin, Stéphane Lemarié, Jean-Pierre Boissin, David Catherine, F. Corolleur, R. Coronini, M. Trommetter. 2003

236 citations recorded by the source corpus.

Subfields: Accounting, Management of Technology and Innovation, Strategy and Management

View Paper: https://www.semanticscholar.org/paper/72a33c6e5da404a1cf38873ee7079ee4c67d252a

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Accounting

In Management of Technology and Innovation

In Strategy and Management

Citations in the corpus

Academic spin-offs at different ages: A case study in search of key obstacles to growth (2009, background): “, leading to different demand for incubation support (e.g. Druilhe and Garnsey 2004; Heirman and Clarysse 2004; Mangematin et al. 2003).”
Government support for SME innovations in the regional industries: The case of government financial support program in South Korea (2014, background): “1 Polic 2 H 1 S a b 1 t a c r h a h i p c 2 m i T S l l d s w m r l i v i v t n c ( n h p T m p v p e S a d o S n t c R s t 560 S. Doh, B. Kim / Research 004; Narula, 2004; Mangematin et al., 2003; George et al., 2002; all and Ziedonis, 2001; Audretsch and Vivarelli, 1996; Acs et al., 994).”
Turning scientific and technological human capital into economic capital: the experience of biotech start-ups in France (2004, background): “In earlier works (Mangematin et al., 2003) we clearly identified two sub-groups with different levels of risk.”
Distant networking: The knowledge acquisition strategies of 'out-cluster' biotechnology firms (2005, background): “Highly innovative and specialized firms developing unique technologies and products are less dependent on the local environment than service firms or suppliers of intermediate products (Mangematin et al., 2002) and co-location appears to be relatively more frequent in relationships with research org”
How do business model and health technology design influence each other? Insights from a longitudinal case study of three academic spin-offs (2014, background): “Furthermore, while innovation scholars have examined the types of business model that are found within the health sector (Mangematin et al., 2003; Pries and Guild, 2011; Willemstein et al., 2007), very few studies have clarified the relationships between business models and technological innovation ”
Open innovation in SMEs—An intermediated network model (2010, background): “For example, Mangematin et al. (2003) show that biotechnology SMEs typically enter into contracts with big industrial groups or run small projects, manufacturing their own products and marketing them.”
What exactly are technological regimes?: Intra-industry heterogeneity in the organization of innovation activities (2007, background): “Mangematin et al. (2003) found that small and medium-sized biotechnology firms in France could be divided into two main groups following different trajectories: one group focusing on market niches and conducting small innovation projects, and another group focusing on radical innovation projects.”
Business Model Dynamics and Innovation: (Re)establishing the Missing Linkages (2011, background): “Mangematin et al. (2003) note that even in a uniform population of firms – such as biotech small and medium-sized enterprises (SMEs) – the logic of the development of firms differs for each business model.”